[go: up one dir, main page]

MX2020008850A - Composicion farmaceutica para infecciones virales. - Google Patents

Composicion farmaceutica para infecciones virales.

Info

Publication number
MX2020008850A
MX2020008850A MX2020008850A MX2020008850A MX2020008850A MX 2020008850 A MX2020008850 A MX 2020008850A MX 2020008850 A MX2020008850 A MX 2020008850A MX 2020008850 A MX2020008850 A MX 2020008850A MX 2020008850 A MX2020008850 A MX 2020008850A
Authority
MX
Mexico
Prior art keywords
disclosed
methods
pharmaceutical composition
viral infections
viral infection
Prior art date
Application number
MX2020008850A
Other languages
English (en)
Inventor
Chad Roy
Original Assignee
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrators Of The Tulane Educational Fund filed Critical The Administrators Of The Tulane Educational Fund
Publication of MX2020008850A publication Critical patent/MX2020008850A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente se describen composiciones tópicas que comprenden una sal de amonio cuaternario y opcionalmente cloruro de amonio y/o dióxido de cloro estabilizado. En la presente también se describen métodos para reducir la gravedad y/o duración de una infección dérmica o de la mucosa como herpes o culebrilla. En la presente también se describen métodos para prevenir la propagación de una infección viral como HIV. En la presente también se describen métodos para tratar una infección viral como queratoconjuntivitis.
MX2020008850A 2018-02-23 2019-02-22 Composicion farmaceutica para infecciones virales. MX2020008850A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862634633P 2018-02-23 2018-02-23
US201862784185P 2018-12-21 2018-12-21
PCT/US2019/019301 WO2019165312A1 (en) 2018-02-23 2019-02-22 Pharmaceutical composition for viral infections

Publications (1)

Publication Number Publication Date
MX2020008850A true MX2020008850A (es) 2021-03-09

Family

ID=67685433

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008850A MX2020008850A (es) 2018-02-23 2019-02-22 Composicion farmaceutica para infecciones virales.

Country Status (8)

Country Link
US (2) US10478407B2 (es)
EP (1) EP3755368A4 (es)
AU (2) AU2019223085A1 (es)
CA (1) CA3092245A1 (es)
IL (1) IL276938A (es)
MX (1) MX2020008850A (es)
WO (1) WO2019165312A1 (es)
ZA (1) ZA202005797B (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283421A (en) * 1979-12-19 1981-08-11 Ray Frank F Anti-viral treatment
US4760079A (en) 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US5686448A (en) 1983-01-10 1997-11-11 Baltech, Inc. Treatment of virus infections with ganglionic blocking agents
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
DK0590024T3 (da) 1991-06-20 1997-10-20 Viro Tex Corp Topisk præparat, der fremmmer heling af herpeslæsioner
US9662360B2 (en) 2008-10-09 2017-05-30 Meritus Corporation Treatment of herpes, pseudomonas, staph, and hepatitis
FR2771637B1 (fr) 1997-12-01 2003-10-24 Hutchinson Utilisation d'un halogenure de dialkyldialkylammonium par voie parenterale dans les infections bacteriennes et virales
US6559189B2 (en) * 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US6759434B2 (en) * 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
CA2396368A1 (en) * 2000-01-10 2001-07-19 Zetetic Research, Inc. Use of a composition comprising two quaternary ammonium compounds and an organometallic compound for treating viral and fungal infections and diseases
EP2280690A2 (en) 2008-04-18 2011-02-09 Nanobio Corporation Methods for treating herpes virus infections
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
CA2845872C (en) * 2011-08-22 2023-03-28 Nanobio Corporation Herpes simplex virus nanoemulsion vaccine
KR20180064399A (ko) * 2015-09-03 2018-06-14 더 어드미니스트레이터 오브 더 튜레인 에듀케이셔널 펀드 다목적 소독 및 멸균 용액을 위한 조성물 및 방법
WO2018144909A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses

Also Published As

Publication number Publication date
AU2025271084A1 (en) 2025-12-18
CA3092245A1 (en) 2019-08-29
IL276938A (en) 2020-10-29
EP3755368A4 (en) 2021-12-22
US20190262286A1 (en) 2019-08-29
WO2019165312A1 (en) 2019-08-29
US20200138749A1 (en) 2020-05-07
EP3755368A1 (en) 2020-12-30
US10478407B2 (en) 2019-11-19
AU2019223085A1 (en) 2020-09-24
ZA202005797B (en) 2024-12-18

Similar Documents

Publication Publication Date Title
BR112021008524A8 (pt) 2-amino-n-heteroaril-nicotinamidas como inibidores de nav 1.8
PH12021550974A1 (en) Stablized pre-fusion rsv f proteins
MX388470B (es) Administración de potenciadores de regulador de la conductancia transmembrana de fibrosis quística (cftr) deuterados.
TN2018000048A1 (en) Antiviral beta-amino acid ester phosphodiamide compounds
HK1258473A1 (zh) 氘代cftr增效剂
BR112016030541A2 (pt) métodos para o tratamento de infecções fúngicas
HK1249893A1 (zh) 氘代vx-661
PH12018501962A1 (en) Stablizied soluble pre-fusion rsv f proteins
MY202069A (en) Pharmaceutical composition
MA40241A (fr) Compositions enrichies stéréochimiquement pour l'administration d'acides nucléiques
WO2020171727A3 (en) Mucoadhesive compositions and uses thereof
PH12019500513A1 (en) Mast cell stabilizers for treatment of hypercytokinemia and viral infection
WO2020154519A3 (en) Methods of treating addiction
EP4424374A3 (en) Crystalline forms of tenofovir alafenamide
MX2017015670A (es) Composicion terapeutica.
MX377639B (es) Desinfectante para manos
PH12018502332A1 (en) Stabilized pre-fusion rsv f proteins
MX2022002196A (es) Composición de liberación retardada de niclosamida y uso antiviral de la misma.
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
WO2018109042A3 (en) Antimicrobial peptides
PH12019550138A1 (en) Pharmaceutical combinations for treating cancer
ZA202308388B (en) Nasal compositions comprising alcaftadine
PH12020551618A1 (en) Erenumab compositions and uses thereof
MX2019013120A (es) Composicion que contiene dioxido de cloro y metodos para su uso.
ZA202005797B (en) Pharmaceutical composition for viral infections